Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SF3A2 |
| Upstream (Parents) |
|---|
| (<<) GNAI2 → SF3A2 |
| (<<) JUND → SF3A2 |
| (<<) MAP2K2 → SF3A2 |
| (<<) PLD3 → SF3A2 |
| (<<) RAVER1 → SF3A2 |
| (<<) RPL36 → SF3A2 |
| (<<) TUBB2C → SF3A2 |
| Downstream (Children) |
|---|
| SF3A2 → ACTN4 (>>) |
| SF3A2 → ATN1 (>>) |
| SF3A2 → CASP3 (>>) |
| SF3A2 → CDH24 (>>) |
| SF3A2 → DMPK (>>) |
| SF3A2 → DVL3 (>>) |
| SF3A2 → EIF4E (>>) |
| SF3A2 → FAM100B (>>) |
| SF3A2 → GNB2 (>>) |
| SF3A2 → HDAC6 (>>) |
| SF3A2 → HGS (>>) |
| SF3A2 → KLF16 (>>) |
| SF3A2 → MAP3K3 (>>) |
| SF3A2 → MAPK3 (>>) |
| SF3A2 → MESDC1 (>>) |
| SF3A2 → MKNK2 (>>) |
| SF3A2 → NAV2 (>>) |
| SF3A2 → NFIX (>>) |
| SF3A2 → PIP5K1C (>>) |
| SF3A2 → PRKACA (>>) |
| SF3A2 → PRKCSH (>>) |
| SF3A2 → PTMS (>>) |
| SF3A2 → RXRA (>>) |
| SF3A2 → SCARB1 (>>) |
| SF3A2 → SPPL2B (>>) |
| SF3A2 → VAC14 (>>) |
| SF3A2 → VPS37B (>>) |
| SF3A2 → ZFP36L1 (>>) |
| SF3A2 → ZFPM1 (>>) |
| SF3A2 → ZNF579 (>>) |
